Short answer
Mirum Pharmaceuticals, Inc. (MIRM) filed an 8-K current report with the SEC on February 25, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Q4 and full-year 2025 earnings release issued Feb 25, 2026: full financials in Exhibit 99.1.
Mirum Pharmaceuticals, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q4 and full-year 2025 earnings release issued Feb 25, 2026: full financials in Exhibit 99.1
- Filing covers period ended Dec 31, 2025: key metrics, guidance, and pipeline updates expected in press release
- "Furnished" not "filed" status means results carry no Section 18 liability: standard for earnings 8-Ks
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Mirum Pharmaceuticals, Inc. 8-K filings
Get the next MIRM 8-K as it lands
Follow MIRM for push alerts, or ask the research agent what this filing means.